Fairmount Healthcare Fund Ii Gp Llc - Net Worth and Insider Trading
Fairmount Healthcare Fund Ii Gp Llc Net Worth
The estimated net worth of Fairmount Healthcare Fund Ii Gp Llc is at least $68 Million dollars as of 2024-12-27. Fairmount Healthcare Fund Ii Gp Llc is the Director, 10% Owner of Viridian Therapeutics Inc and owns about 3,445,813 shares of Viridian Therapeutics Inc (VRDN) stock worth over $68 Million. Details can be seen in Fairmount Healthcare Fund Ii Gp Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fairmount Healthcare Fund Ii Gp Llc has not made any transactions after 2024-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fairmount Healthcare Fund Ii Gp Llc
Fairmount Healthcare Fund Ii Gp Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fairmount Healthcare Fund Ii Gp Llc owns 1 companies in total, including Viridian Therapeutics Inc (VRDN) .
Insider Ownership Summary of Fairmount Healthcare Fund Ii Gp Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2024-09-13 | director & other: See Remarks |
Fairmount Healthcare Fund Ii Gp Llc Latest Holdings Summary
Fairmount Healthcare Fund Ii Gp Llc currently owns a total of 1 stock. Fairmount Healthcare Fund Ii Gp Llc owns 3,445,813 shares of Viridian Therapeutics Inc (VRDN) as of September 13, 2024, with a value of $68 Million.
Latest Holdings of Fairmount Healthcare Fund Ii Gp Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2024-09-13 | 3,445,813 | 19.83 | 68,330,472 |
Holding Weightings of Fairmount Healthcare Fund Ii Gp Llc
Fairmount Healthcare Fund Ii Gp Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Fairmount Healthcare Fund Ii Gp Llc has made a total of 1 transactions in Viridian Therapeutics Inc (VRDN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Viridian Therapeutics Inc is the acquisition of 1,600,000 shares on September 13, 2024, which cost Fairmount Healthcare Fund Ii Gp Llc around $30 Million.
Insider Trading History of Fairmount Healthcare Fund Ii Gp Llc
- 1
Fairmount Healthcare Fund Ii Gp Llc Trading Performance
GuruFocus tracks the stock performance after each of Fairmount Healthcare Fund Ii Gp Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fairmount Healthcare Fund Ii Gp Llc is -19.08%. GuruFocus also compares Fairmount Healthcare Fund Ii Gp Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fairmount Healthcare Fund Ii Gp Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fairmount Healthcare Fund Ii Gp Llc's insider trading performs compared to the benchmark.
Performance of Fairmount Healthcare Fund Ii Gp Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.12 |  | | | | |
| Relative Return to S&P 500(%) | 3.76 | | | | | |
Fairmount Healthcare Fund Ii Gp Llc Ownership Network
Fairmount Healthcare Fund Ii Gp Llc Owned Company Details
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Fairmount Healthcare Fund Ii Gp Llc is the director & other: See Remarks of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include Chief Operating Officer Thomas W. Beetham , director & President and CEO Stephen F. Mahoney , and director & other: See Remarks Fairmount Healthcare Fund Gp Llc .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Fairmount Healthcare Fund Ii Gp Llc made 1 insider transaction in Viridian Therapeutics Inc (VRDN) with a net purchase of 1,600,000. Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc , a net purchase of 21,400 shares made by Stephen F. Mahoney , and a net purchase of 5,000 shares made by Thomas W. Beetham .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,102,590 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
Fairmount Healthcare Fund Ii Gp Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Fairmount Healthcare Fund Ii Gp Llc. You might contact Fairmount Healthcare Fund Ii Gp Llc via mailing address: 2001 Market Street, Suite 2500, Philadelphia Pa 19103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
